UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Skin biopsy for the evaluation of peripheral nerve disease

Authors
A Gordon Smith, MD
Summer Gibson, MD
Section Editor
Jeremy M Shefner, MD, PhD
Deputy Editor
John F Dashe, MD, PhD

INTRODUCTION

The study of peripheral nerve disorders has been facilitated by the fact that anatomic structures may be reasonably and safely biopsied without major morbidity.

Muscle biopsy allows for distinction of neurogenic and myopathic conditions, and for detailed characterization of primary muscle disease. However, it is not particularly helpful in distinguishing between different types of peripheral nerve disease.

Historically, biopsy of a sensory nerve with a specific cutaneous field was necessary to establish an anatomic diagnosis of peripheral nerve disease. Cutaneous sensory nerve biopsy remains a standard diagnostic tool in the evaluation of peripheral neuropathies. The most common nerve biopsied is the sural sensory nerve in the calf. While the surgical procedure is generally well tolerated, risks include infection, other surgical morbidity, numbness along the lateral foot, and neuropathic pain [1]. Cutaneous nerve biopsy is potentially useful for a limited number of conditions, including peripheral nerve vasculitis, amyloid neuropathy, atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy, and certain forms of toxic (eg, n-hexane) and hereditary neuropathies [2]. For most other causes of peripheral neuropathy, nerve biopsy reveals evidence of axonal loss but is not particularly helpful for determining etiology. Nerve biopsy as a research tool is limited by the potential risks and by the fact that it can only be performed twice (once on each side).The evaluation of small unmyelinated axons by nerve biopsy is challenging, even with electron microscopy. Other pathologic techniques must be used to evaluate small fiber neuropathies.

Skin biopsy with assessment of dermal and epidermal innervation is a standard diagnostic test at many facilities and a powerful research tool.  

This chapter will review the technique of skin biopsy in the evaluation and study of peripheral nerve disease. Other diagnostic methods for the evaluation of neuropathy and neuromuscular disease are discussed elsewhere. (See "Overview of electromyography" and "Overview of nerve conduction studies".)

       

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon May 09 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Ruth A, Schulmeyer FJ, Roesch M, et al. Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy. Clin Neurol Neurosurg 2005; 107:214.
  2. England JD, Gronseth GS, Franklin G, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72:177.
  3. Langerhans P. Ueber die nerven der menschlichen haut. Virchows Arch 1868; 44:325.
  4. Dalsgaard CJ, Rydh M, Haegerstrand A. Cutaneous innervation in man visualized with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistry 1989; 92:385.
  5. Lauria G. Innervation of the human epidermis. A historical review. Ital J Neurol Sci 1999; 20:63.
  6. Dyck PJ, Winkelmann RK, Bolton CF. Quantitation of Meissner's corpuscles in hereditary neurologic disorders. Charcot-Marie-Tooth disease, Roussy-Levy syndrome, Dejerine-Sottas disease, hereditary sensory neuropathy, spinocerebellar degenerations, and hereditary spastic paraplegia. Neurology 1966; 16:10.
  7. Wilkinson KD, Lee KM, Deshpande S, et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989; 246:670.
  8. Levy DM, Terenghi G, Gu XH, et al. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 1992; 35:889.
  9. Lauria G, Lombardi R, Camozzi F, Devigili G. Skin biopsy for the diagnosis of peripheral neuropathy. Histopathology 2009; 54:273.
  10. McCarthy BG, Hsieh ST, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995; 45:1848.
  11. McArthur JC, Stocks EA, Hauer P, et al. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998; 55:1513.
  12. Lauria G, Bakkers M, Schmitz C, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010; 15:202.
  13. McArthur JC, Griffin JW. Another tool for the neurologist's toolbox. Ann Neurol 2005; 57:163.
  14. Kanitakis J. Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol 2002; 12:390.
  15. Liu Y, Fan X, Wei Y, et al. Intraepidermal nerve fiber density of healthy human. Neurol Res 2014; 36:911.
  16. Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008; 131:1912.
  17. Oaklander AL, Romans K, Horasek S, et al. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol 1998; 44:789.
  18. Li J, Bai Y, Ghandour K, et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 2005; 128:1168.
  19. Sommer C. Skin biopsy as a diagnostic tool. Curr Opin Neurol 2008; 21:563.
  20. Lombardi R, Erne B, Lauria G, et al. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy. Ann Neurol 2005; 57:180.
  21. Narayanaswamy H, Facer P, Misra VP, et al. A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies. J Clin Neurosci 2012; 19:1490.
  22. Lauria G. Small fibre neuropathies. Curr Opin Neurol 2005; 18:591.
  23. Sommer C, Lauria G. Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 2007; 6:632.
  24. Vlcková-Moravcová E, Bednarík J, Dusek L, et al. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve 2008; 37:50.
  25. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002; 26:173.
  26. Boruchow SA, Gibbons CH. Utility of skin biopsy in management of small fiber neuropathy. Muscle Nerve 2013; 48:877.
  27. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2010; 15:79.
  28. Gibbons CH, Griffin JW, Polydefkis M, et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006; 66:256.
  29. Lauria G, Morbin M, Lombardi R, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003; 61:631.
  30. Gorson KC, Herrmann DN, Thiagarajan R, et al. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry 2008; 79:163.
  31. Holland NR, Crawford TO, Hauer P, et al. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998; 44:47.
  32. Khan S, Zhou L. Characterization of non-length-dependent small-fiber sensory neuropathy. Muscle Nerve 2012; 45:86.
  33. Gemignani F, Ferrari G, Vitetta F, et al. Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation. J Neurol Neurosurg Psychiatry 2010; 81:731.
  34. Gorson KC. The 'eyes' have it: a window into non-length-dependent small fibre neuropathy with corneal confocal microscopy. J Neurol Neurosurg Psychiatry 2010; 81:708.
  35. Evans BA, Lussky D, Knezevic W. The peripheral autonomic surface potential in suspected small fiber peripheral neuropathy [abstract]. Muscle Nerve 1988; 11:982.
  36. Ravits JM. AAEM minimonograph #48: autonomic nervous system testing. Muscle Nerve 1997; 20:919.
  37. Freeman R, Chase KP, Risk MR. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology 2003; 60:465.
  38. Peltier A, Smith AG, Russell JW, et al. Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve 2009; 39:529.
  39. Singer W, Spies JM, McArthur J, et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology 2004; 62:612.
  40. Smith AG, Howard JR, Kroll R, et al. The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J Neurol Sci 2005; 228:65.
  41. Herrmann DN, Griffin JW, Hauer P, et al. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999; 53:1634.
  42. Holland NR, Stocks A, Hauer P, et al. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 1997; 48:708.
  43. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996; 47:1042.
  44. Smith AG, Ramachandran P, Tripp S, Singleton JR. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2001; 57:1701.
  45. Tseng MT, Hsieh SC, Shun CT, et al. Skin denervation and cutaneous vasculitis in systemic lupus erythematosus. Brain 2006; 129:977.
  46. Elghetany MT, Saleem A. Methods for staining amyloid in tissues: a review. Stain Technol 1988; 63:201.
  47. Periquet MI, Novak V, Collins MP, et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 1999; 53:1641.
  48. Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006; 29:1294.
  49. Weintraub MI, Herrmann DN, Smith AG, et al. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial. Arch Phys Med Rehabil 2009; 90:1102.
  50. Gordon Smith A, Robinson Singleton J. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci 2006; 242:9.
  51. Polydefkis M, Hauer P, Sheth S, et al. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004; 127:1606.